100 related articles for article (PubMed ID: 15001847)
1. New treatment boosts outlook for breast cancer survivors.
Mayo Clin Womens Healthsource; 2004 Mar; 8(3):3. PubMed ID: 15001847
[No Abstract] [Full Text] [Related]
2. Anastrozole called breast cancer "lifesaver". Recipients showed a 40 percent decrease in relapse risk when switched to anastrazole after tamoxifen.
Health News; 2005 Dec; 11(12):13-4. PubMed ID: 16416553
[No Abstract] [Full Text] [Related]
3. Breast-cancer drug letrozole picks up where tamoxifen leaves off. But we don't know who stands to benefit the most from this follow-up approach.
Runowicz CD
Health News; 2003 Dec; 9(12):4-5. PubMed ID: 14679962
[No Abstract] [Full Text] [Related]
4. Alternative to tamoxifen effective for preventing breast cancer recurrence.
Mayo Clin Womens Healthsource; 2005 May; 9(5):3. PubMed ID: 15891689
[No Abstract] [Full Text] [Related]
5. Breast cancer drug shows promise for some survivors.
Levenson D
Rep Med Guidel Outcomes Res; 2003 Oct; 14(21):7-9. PubMed ID: 14628765
[No Abstract] [Full Text] [Related]
6. Long-term insurance for breast cancer survivors.
Johns Hopkins Med Lett Health After 50; 2004 Apr; 16(2):3, 7. PubMed ID: 15088564
[No Abstract] [Full Text] [Related]
7. Letrozole improves disease-free survival vs tamoxifen in adjuvant treatment of early breast cancer.
Oncology (Williston Park); 2005 Mar; 19(3):277, 360. PubMed ID: 15828547
[No Abstract] [Full Text] [Related]
8. Drugs may improve long-term outcomes after breast cancer.
Mayo Clin Health Lett; 2004 Mar; 22(3):4. PubMed ID: 15000065
[No Abstract] [Full Text] [Related]
9. Letrozole in breast cancer.
Harris SR
N Engl J Med; 2004 Feb; 350(7):727-30; author reply 727-30. PubMed ID: 14971059
[No Abstract] [Full Text] [Related]
10. Doctors test drug to prevent cancer in high risk women.
Kmietowicz Z
BMJ; 2003 Oct; 327(7418):768. PubMed ID: 14525859
[No Abstract] [Full Text] [Related]
11. Efficacy of anastrozole on local recurrence in patients with favorable early breast cancer.
Dizdar O; Harputluoglu H; Altundag K
Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1651; author reply 1651. PubMed ID: 18035222
[No Abstract] [Full Text] [Related]
12. Preventing relapse beyond 5 years: the MA.17 extended adjuvant trial.
Goss PE
Semin Oncol; 2006 Apr; 33(2 Suppl 7):S8-12. PubMed ID: 16730271
[TBL] [Abstract][Full Text] [Related]
13. The use of early adjuvant aromatase inhibitor therapy: contributions from the BIG 1-98 letrozole trial.
Forbes JF
Semin Oncol; 2006 Apr; 33(2 Suppl 7):S2-7. PubMed ID: 16730270
[TBL] [Abstract][Full Text] [Related]
14. Latest studies hint at survival advantage with aromatase inhibitors in early breast cancer.
Tuma RS
J Natl Cancer Inst; 2006 Jan; 98(2):86-7. PubMed ID: 16418506
[No Abstract] [Full Text] [Related]
15. Switching to anastrozole after tamoxifen improves survival in postmenopausal women with breast cancer.
Boccardo F
Nat Clin Pract Oncol; 2008 Feb; 5(2):76-7. PubMed ID: 17998944
[No Abstract] [Full Text] [Related]
16. Resumption of menses with initiation of letrozole after five years of amenorrhea on tamoxifen: caution needed when using tamoxifen followed by aromatase inhibitors.
Hargis JB; Nakajima ST
Cancer Invest; 2006 Mar; 24(2):174-7. PubMed ID: 16537187
[TBL] [Abstract][Full Text] [Related]
17. Superiority of letrozole to tamoxifen in the first-line treatment of advanced breast cancer: evidence from metastatic subgroups and a test of functional ability.
Mouridsen H; Sun Y; Gershanovich M; Perez-Carrion R; Becquart D; Chaudri-Ross HA; Lang R
Oncologist; 2004; 9(5):489-96. PubMed ID: 15477633
[TBL] [Abstract][Full Text] [Related]
18. Benefit and projected cost-effectiveness of anastrozole versus tamoxifen as initial adjuvant therapy for patients with early-stage estrogen receptor-positive breast cancer.
Hillner BE
Cancer; 2004 Sep; 101(6):1311-22. PubMed ID: 15368322
[TBL] [Abstract][Full Text] [Related]
19. Review of the ATAC study: tamoxifen versus anastrozole in early-stage breast cancer.
Needleman SJ; Tobias JS
Expert Rev Anticancer Ther; 2008 Dec; 8(12):1871-81. PubMed ID: 19046107
[TBL] [Abstract][Full Text] [Related]
20. Clinical research. No lifeline for proposed breast cancer prevention trial.
Kaiser J
Science; 2007 Jun; 316(5832):1679. PubMed ID: 17588904
[No Abstract] [Full Text] [Related]
[Next] [New Search]
